The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[4-(4-chloro-phenoxy)-phenyl]-1H-benzoimidazole-5-carboxylic acid methylamide ID: ALA3982809
PubChem CID: 10110159
Max Phase: Preclinical
Molecular Formula: C21H16ClN3O2
Molecular Weight: 377.83
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
Standard InChI: InChI=1S/C21H16ClN3O2/c1-23-21(26)14-4-11-18-19(12-14)25-20(24-18)13-2-7-16(8-3-13)27-17-9-5-15(22)6-10-17/h2-12H,1H3,(H,23,26)(H,24,25)
Standard InChI Key: SPMJCKLIOKTQLW-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
10.8421 -7.4316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5927 -7.7682 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1437 -7.1567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7309 -6.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9275 -6.6148 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9650 -7.1567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3736 -6.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9650 -5.7331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1437 -5.7331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1949 -6.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6076 -7.1567 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6076 -5.7331 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1949 -5.0212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1302 -7.8444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1302 -8.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4184 -9.0743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7065 -8.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7065 -7.8444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4184 -7.4316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9988 -9.0743 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2870 -8.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5752 -9.0743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8633 -8.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8633 -7.8444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5752 -7.4316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2870 -7.8444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1515 -7.4316 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
3 6 2 0
10 11 2 0
12 13 1 0
10 12 1 0
7 10 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
21 26 2 0
20 21 1 0
24 27 1 0
17 20 1 0
1 14 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.83Molecular Weight (Monoisotopic): 377.0931AlogP: 5.04#Rotatable Bonds: 4Polar Surface Area: 67.01Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.07CX Basic pKa: 4.39CX LogP: 4.46CX LogD: 4.46Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -1.28
References 1. (2007) 2-phenyl benzimidazoles and imidazo-4,5|-pyridines as CDS1/CHK2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer,